Epigral Beheer
Beheer criteriumcontroles 2/4
Momenteel beschikken wij niet over voldoende informatie over de CEO.
Belangrijke informatie
Kaushal Soparkar
Algemeen directeur
₹43.9m
Totale compensatie
Percentage CEO-salaris | 9.2% |
Dienstverband CEO | 8.5yrs |
Eigendom CEO | 0.5% |
Management gemiddelde ambtstermijn | geen gegevens |
Gemiddelde ambtstermijn bestuur | 8.5yrs |
Recente managementupdates
Recent updates
Epigral Limited's (NSE:EPIGRAL) Shares Leap 29% Yet They're Still Not Telling The Full Story
Jul 04Epigral Limited (NSE:EPIGRAL) Looks Just Right With A 27% Price Jump
Apr 19Epigral Limited (NSE:EPIGRAL) Soars 28% But It's A Story Of Risk Vs Reward
Feb 23Epigral (NSE:EPIGRAL) Might Be Having Difficulty Using Its Capital Effectively
Feb 21Capital Investment Trends At Meghmani Finechem (NSE:MFL) Look Strong
Apr 05With EPS Growth And More, Meghmani Finechem (NSE:MFL) Makes An Interesting Case
Sep 28Meghmani Finechem's (NSE:MFL) Promising Earnings May Rest On Soft Foundations
May 03Meghmani Finechem Limited's (NSE:MFL) Business Is Yet to Catch Up With Its Share Price
Nov 22Analyse CEO-vergoeding
Datum | Totale vergoeding | Salaris | Bedrijfswinsten |
---|---|---|---|
Jun 30 2024 | n/a | n/a | ₹3b |
Mar 31 2024 | ₹44m | ₹4m | ₹2b |
Dec 31 2023 | n/a | n/a | ₹2b |
Sep 30 2023 | n/a | n/a | ₹2b |
Jun 30 2023 | n/a | n/a | ₹3b |
Mar 31 2023 | ₹62m | ₹4m | ₹4b |
Dec 31 2022 | n/a | n/a | ₹4b |
Sep 30 2022 | n/a | n/a | ₹4b |
Jun 30 2022 | n/a | n/a | ₹3b |
Mar 31 2022 | ₹32m | ₹4m | ₹3b |
Mar 31 2021 | ₹30m | ₹3m | ₹1b |
Mar 31 2020 | ₹28m | ₹4m | ₹1b |
Mar 31 2019 | ₹64m | ₹4m | ₹2b |
Mar 31 2018 | ₹9m | ₹4m | ₹2b |
Compensatie versus markt: De totale vergoeding ($USD 522.10K ) Kaushal } ligt boven het gemiddelde voor bedrijven van vergelijkbare omvang in de Indian markt ($USD 364.13K ).
Compensatie versus inkomsten: De vergoeding van Kaushal is het afgelopen jaar in lijn geweest met de bedrijfsprestaties.
CEO
Kaushal Soparkar (41 yo)
8.5yrs
Tenure
₹43,907,000
Compensatie
Mr. Kaushal Ashisbhai Soparkar serves as Chief Executive Officer and until August 5, 2023 served as Managing Director and serves as Director of Epigral Limited (formerly known as Meghmani Finechem Limited)...
Bestuursleden
Naam | Positie | Tenure | Compensatie | Eigendom |
---|---|---|---|---|
Chairman & MD | 8.5yrs | ₹43.91m | 7.53% ₹ 7.0b | |
CEO & Executive Director | 8.5yrs | ₹43.91m | 0.51% ₹ 474.7m | |
Independent Non-Executive Director | 3.5yrs | ₹700.00k | geen gegevens | |
Non-Executive Director | 8.5yrs | ₹25.32m | 1.68% ₹ 1.6b | |
Independent Non-Executive Director | 3.5yrs | ₹500.00k | geen gegevens | |
Non-Executive Director | 8.5yrs | ₹41.27m | 5.41% ₹ 5.0b | |
Independent Non-Executive Director | 7.5yrs | ₹875.00k | geen gegevens | |
Non-Executive Director | 8.5yrs | ₹17.35m | 2.29% ₹ 2.1b | |
Independent Non-Executive (Woman) Director | 9.7yrs | ₹725.00k | geen gegevens | |
Independent Non-Executive Director | 3.5yrs | ₹400.00k | 0.010% ₹ 9.3m |
8.5yrs
Gemiddelde duur
43yo
Gemiddelde leeftijd
Ervaren bestuur: De raad van bestuur van EPIGRAL wordt beschouwd als ervaren (gemiddelde ambtstermijn 8.5 jaar).